5‑Amino‑1MQ is a research‑grade small molecule inhibitor developed to selectively block the activity of Nicotinamide N‑Methyltransferase (NNMT) — an enzyme that plays an important role in metabolic pathways, methylation regulation, and energy homeostasis. In laboratory studies, this compound is used to explore how NNMT inhibition affects metabolic signaling, lipid metabolism, glucose regulation, and epigenetic methylation processes in cells and model systems.

The product is supplied as a white to off‑white crystalline powder that is soluble in common laboratory solvents. High quality and consistency are ensured through analytical verification (e.g., HPLC, MS) and documented on an accompanying Certificate of Analysis (COA), which confirms purity, identity, and storage parameters.

5‑Amino‑1MQ is intended strictly for laboratory research use and is not approved for therapeutic, clinical, or human applications. It is widely used in metabolic and biochemical research, especially in studies focused on enzyme inhibition and metabolic pathways.